News
This article was written by Follow Like millions of other investors, I got Robinhood and started trading during the pandemic. Unlike most of those...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Merck & Co., Inc. (NYSE:MRK) Q2 2025 Earnings Conference Call July 29, 2025 9:00 AM ET Company Participants Caroline A. Litchfield – Executive VP...
News
This article was written by Follow Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years,...
News
This article was written by Follow I’m an ex-Project Manager for the luxury real estate auction company, Concierge Auctions, that has been studying stock...
News
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded...
News
PowerFleet, Inc. (NASDAQ:AIOT) Q4 2025 Earnings Call June 16, 2025 8:30 AM ET Company Participants Craig Fisk – Executive Vice President ofSales & Marketing...
News
This article was written by Follow I aim to invest in companies with perfect qualitative attributes, buy them at an attractive price based on...
News
This article was written by Follow At PropNotes, we focus on finding high-yield investment opportunities for individual investors.With our background in professional Prop Trading,...
News
American Express Company (NYSE:AXP) Morgan Stanley US Financials Conference June 11, 2025 9:45 AM ET Company Participants Christophe Y. Le Caillec – Chief Financial...
News
Merck & Co., Inc. (NYSE:MRK) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 10:00 AM ET Company Participants Dean Y. Li –...
News
This article was written by Follow Donovan Jones is a research specialist with 15 years of experience identifying opportunities for IPOs and public software...
News
This article was written by Follow About My Writing: I am currently focused on income investing through either common shares, preferred shares, or bonds. ...
News
This article was written by Follow Moretus Research delivers state-of-the-art, buy-side quality equity research for serious investors seeking clarity, conviction, and alpha. Focused on...
